Related Experiment Video
Updated: Aug 11, 2026

09:12
Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
Off pump coronary artery bypass grafting - midterm results
P Massoudy1, M Thielmann, P Kienbaum
1Department of Thoracic and Cardiovascular Surgery,University Duisburg-Essen, West German Heart Center Essen, Germany. parwis.massoudy@uni-essen.de
European Journal of Medical Research
|March 1, 2006
Summary
Off-pump coronary artery bypass (OPCAB) grafting shows acceptable mid-term outcomes, with good freedom from death and re-intervention. Patients experienced sustained clinical improvement, indicated by reduced angina classifications after OPCAB surgery.
Area of Science:
- Cardiovascular Surgery
- Cardiac Surgery Outcomes
- Minimally Invasive Cardiac Surgery
Background:
- Off-pump coronary artery bypass (OPCAB) grafting remains a topic of debate within cardiac surgery.
- While early results are promising, mid-term data on angina recurrence and freedom from adverse events are less frequently reported.
Purpose of the Study:
- To evaluate mid-term clinical outcomes and graft patency following OPCAB grafting.
- To assess freedom from death and re-intervention in a consecutive OPCAB patient cohort.
- To analyze changes in angina and heart failure classifications post-OPCAB surgery.
Main Methods:
- A cohort of 107 OPCAB patients (mean age 63, 77% male) were systematically followed up.
- Pre- and post-operative NYHA and CCS classifications were compared.
- Freedom from death and re-intervention was assessed, with a subset undergoing angiography or MSCT.
Main Results:
- 30-day mortality was 2%. At 5.5 years, freedom from death was 91% and freedom from re-intervention was 80%.
- Significant reductions in CCS (2.8 to 1.8) and NYHA (2.7 to 2.2) classifications were observed.
- Graft patency rates at a mean follow-up of 2.2 years were 91% for LITA and 83% for venous grafts.
Conclusions:
- OPCAB grafting in this high-risk cohort demonstrates acceptable mid-term freedom from death and re-intervention.
- Sustained clinical improvement is evident through significant reductions in angina and heart failure symptoms.
- Graft patency rates are within the expected range, supporting the durability of OPCAB procedures.
